|
Volumn 43, Issue 2, 2000, Pages 440-443
|
Validation of the Sapporo criteria for antiphospholipid syndrome
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINUCLEAR ANTIBODY;
BETA2 GLYCOPROTEIN 1;
CARDIOLIPIN ANTIBODY;
DNA ANTIBODY;
IMMUNOGLOBULIN A ANTIBODY;
IMMUNOGLOBULIN G ANTIBODY;
IMMUNOGLOBULIN M ANTIBODY;
LUPUS ANTICOAGULANT;
ADULT;
ANTIPHOSPHOLIPID SYNDROME;
ARTICLE;
DISEASE CLASSIFICATION;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PREDICTION;
PRIORITY JOURNAL;
SEROLOGY;
SYSTEMIC LUPUS ERYTHEMATOSUS;
VALIDATION PROCESS;
ADULT;
ANTIBODIES;
ANTIBODIES, ANTICARDIOLIPIN;
ANTIPHOSPHOLIPID SYNDROME;
BETA 2-GLYCOPROTEIN I;
FALSE NEGATIVE REACTIONS;
FEMALE;
GLYCOPROTEINS;
HUMANS;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
MALE;
MIDDLE AGED;
PREGNANCY;
REPRODUCIBILITY OF RESULTS;
SKIN DISEASES, VASCULAR;
THROMBOCYTOPENIA;
|
EID: 0034122051
PISSN: 00043591
EISSN: None
Source Type: Journal
DOI: 10.1002/1529-0131(200002)43:2<440::AID-ANR26>3.0.CO;2-N Document Type: Article |
Times cited : (196)
|
References (3)
|